Survey of Buprenorphine Use Among "Out of Care" Population in France (P04933)(COMPLETED) - Full Text View

Sponsored by:	Schering-Plough
Information provided by:	Schering-Plough
ClinicalTrials.gov Identifier:	NCT00756353

Purpose

This study was a survey of drug users who obtain buprenorphine from the black market and have used buprenorphine during the last month. Subjects were surveyed at various locations (streets, railway stations, etc.) with a few simple questions in order to describe the use of buprenorphine in this "out of care" population.

Condition
Drug Addiction

Study Type:	Observational
Study Design:	Cross-Sectional
Official Title:	Out of Care Patient Survey

Resource links provided by NLM:

Drug Information available for: Buprenorphine Buprenorphine hydrochloride

U.S. FDA Resources

Further study details as provided by Schering-Plough:

Primary Outcome Measures:

The objective of this survey is to describe quantitatively and qualitatively, the use of buprenorphine in the population who obtain buprenorphine only on black market or both on black market and in pharmacy. [ Time Frame: Not Applicable, cross-sectional description. ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

This survey will provide data on patients in regards to their own experience in drug addiction. [ Time Frame: Not Applicable, cross-sectional description. ] [ Designated as safety issue: No ]

Biospecimen Retention: None Retained

Biospecimen Description:

Enrollment:	600
Study Start Date:	June 2006
Study Completion Date:	December 2006
Primary Completion Date:	December 2006 (Final data collection date for primary outcome measure)

Groups/Cohorts
Wave 1
Wave 2

Detailed Description:

Participants were found from various places and using a "snow ball" technique.

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

The population in this survey includes drug users who are in the "out of care" population, found in various places (streets, railway stations) and via the "snow ball" technique.

Criteria

Inclusion Criteria:

Drug users who have obtained buprenorphine only on the black market or both on black market and in pharmacy.

Exclusion Criteria:

Patients who have obtained buprenorphine only from the pharmacy.

Contacts and Locations

No Contacts or Locations Provided

More Information

No publications provided

Responsible Party:	Schering-Plough ( Head, Clinical Trials Registry & Results Disclosure Group )
Study ID Numbers:	P04933
Study First Received:	September 19, 2008
Last Updated:	September 19, 2008
ClinicalTrials.gov Identifier:	NCT00756353 History of Changes
Health Authority:	France: Not Applicable

Keywords provided by Schering-Plough:

Heroin
Buprenorphine use

Study placed in the following topic categories:

Buprenorphine
Behavior, Addictive
Heroin
Mental Disorders
Narcotic Antagonists
Substance-Related Disorders

Central Nervous System Depressants
Disorders of Environmental Origin
Narcotics
Peripheral Nervous System Agents
Analgesics
Analgesics, Opioid

Additional relevant MeSH terms:

Narcotic Antagonists
Physiological Effects of Drugs
Disorders of Environmental Origin
Central Nervous System Depressants
Narcotics
Pharmacologic Actions
Buprenorphine
Mental Disorders

Sensory System Agents
Therapeutic Uses
Substance-Related Disorders
Analgesics
Peripheral Nervous System Agents
Central Nervous System Agents
Analgesics, Opioid

ClinicalTrials.gov processed this record on September 10, 2009